Effects of moxonidine, an imidazoline antihypertensive agent, on second messenger systems in rat brain
- 1 October 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 269 (2) , 273-276
- https://doi.org/10.1016/0922-4106(94)90097-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medullaBiochemical Pharmacology, 1993
- Cloning and expression of an adenylyl cyclase localized to the corpus striatumNature, 1993
- Central Cardiovascular Effects of Rilmenidine and Neuropeptide Y in the Conscious Spontaneously Hypertensive Rat: Haemodynamic and Biochemical Evidence for a Negative InteractionJournal of Cardiovascular Pharmacology, 1992
- Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cellsBiochemical Pharmacology, 1991
- Differences in imidazoline and phenylethylamine alpha-adrenergic agonists: Comparison of binding affinity and phosphoinositide responseNeuropharmacology, 1991
- Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 areaEuropean Journal of Pharmacology, 1991
- Effect of α-methylserotonin on serotonin receptor-coupled phosphoinositide breakdown in rat cerebral cortexNeurochemistry International, 1990
- Are there multiple imidazoline binding sites?Trends in Pharmacological Sciences, 1989
- Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medullaEuropean Journal of Pharmacology, 1987
- A procedure for measuring α2-adrenergic receptor-mediated inhibition of cyclic AMP accumulation in rat brain slicesBrain Research, 1986